Citations 1
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
Agathangelidis, Andreas , Hadzidimitriou, Anastasia , Sutton, Lesley-Ann, Minga, Eva, Scarfò, Lydia , Davis, Zadie , Yan, Xiao‐Jie , Plevová, Karla , Sandberg, Yorick , Vojdeman, Fie Juhl , Boudjogra, Myriam, Τζένου, Τατιάνα , Chatzouli, Maria, Chu, Charles C. , Veronese, Silvio , Gardiner, Anne, Mansouri, Larry, Smedby, Karin E. , Pedersen, Lone Bredo , Moreno, Denis, Lom, Kirsten van, Giudicelli, Véronique , Francová, Hana Skuhrová, Nguyen‐Khac, Florence , Juliusson, Gunnar , Anagnostopoulos, Αchilles , Lefranc, Marie‐Paule , Facco, Monica , Trentin, Livio , Catherwood, Mark , Montillo, Marco , Geisler, Christian H., Pospı́šilová, Šárka , Oscier, David , Jelinek, Diane F., Darzentas, Nikos , Belessi, Chrysoula, Davi, Frédéric , Ghia, Paolo , Rosenquist, Richard , Σταματόπουλος, Κώστας , Baliakas, Panagiotis , Tsanousa, Athina , Shanafelt, Tait D. , Panagiotidis, Panagiotis T. , Angelis, Lefteris , Langerak, Anton W. , Chiorazzi, Nicholas , Ghia, Paolo , Rosenquist, Richard
Blood | January 29, 2015 | Volume: 125 | Issue: 5 | Pages: 856-859
Key Points CLL stereotyped subset #2 (IGHV3-21/IGLV3-21) is uniformly aggressive independently of somatic hypermutation status. The prognosis for non–subset #2/IGHV3-21 CLL resembles that of the remaining CLL cases with similar somatic hypermutation status.